Abstract |
Ethanolic extract of Hydrastis canadensis has been tested for its possible anti- cancer potentials against p-dimethylaminoazobenzene (p-DAB) induced hepatocarcinogenesis in mice. Mice were chronically fed p-dimethylaminoazobenzene (p-DAB) and phenobarbital (PB), two hepato- carcinogens for 1, 2, 3 and 4 months, respectively, and were divided into sub-groups: i) fed normal low protein diet (Gr. I, normal control); ii) fed diet mixed with 0.06% p-DAB at a daily dose of 165 mg/kg b.w. per mouse plus 0.05% PB plus 0.06 ml 90% alcohol (vehicle of the crude extract) (Gr. II, carcinogen treated); iii) fed diet mixed with p-DAB and PB at the same daily dose plus crude extract of Hydrastis canadensis (Gr. III, drug treated). Several biochemical parameters like acid and alkaline phosphatases, alanine amino-, aspartate amino-, and gamma glutamyl- transferases, lipid peroxidation, reduced glutathione content, lactate dehydrogenase, catalase and glucose-6-phosphate dehydrogenase activities and electron microscopy of liver in different groups of treated and control mice were studied. A critical analysis of results of these studies suggested anti- cancer potentials of the drug suitable for use as a supportive complementary medicine in liver cancer.
|
Authors | Susanta Roy Karmakar, Surjyo Jyoti Biswas, Anisur Rahman Khuda-Bukhsh |
Journal | Asian Pacific journal of cancer prevention : APJCP
(Asian Pac J Cancer Prev)
Vol. 11
Issue 2
Pg. 545-51
( 2010)
ISSN: 2476-762X [Electronic] Thailand |
PMID | 20843149
(Publication Type: Journal Article)
|
Chemical References |
- Carcinogens
- Plant Extracts
- p-Dimethylaminoazobenzene
- Phenobarbital
|
Topics |
- Animals
- Carcinogens
(toxicity)
- Carcinoma, Hepatocellular
(chemically induced, drug therapy, metabolism)
- Chromosome Aberrations
- Female
- Hydrastis
(chemistry)
- Lipid Peroxidation
(drug effects)
- Liver
(drug effects)
- Liver Neoplasms, Experimental
(chemically induced, drug therapy, metabolism)
- Male
- Mice
- Phenobarbital
(toxicity)
- Phytotherapy
- Plant Extracts
(therapeutic use)
- Treatment Outcome
- p-Dimethylaminoazobenzene
(toxicity)
|